Carmot Therapeutics Inc. — Form D
Carmot Therapeutics Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-25. The offering totals $15.4M, of which $10.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-25
- Form: D
- Accession: 0001490109-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.4M
- Amount sold: $10.8M
- Remaining: $4.6M
- Investors: 4
- Date of first sale: 2017-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-293514
Issuer
- Name: Carmot Therapeutics Inc.
- CIK: 0001490109
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 409 ILLINOIS STREET, SAN FRANCISCO, CA, 94158
- Phone: 510-828-0102
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Daniel A Erlanson | Director | San Francisco, CA |
| Larry K Lasky | Director | San Francisco, CA |
| Aetna Wun Trombley | Director | San Francisco, CA |
| Daniel A Erlanson | Executive Officer | San Francisco, CA |
| Anne K Phillips, M.D. | Director | Berkeley, CA |
| Tim K Kutzkey | Director | Berkeley, CA |
| Peter K Svennilson | Director | Berkeley, CA |
| Aetna Wun K Trombley | Director | Berkeley, CA |
| Timothy K Garnett | Director | Berkeley, CA |
| Stig K Hansen, Ph.D. | Director | Berkeley, CA |
| Heather K Turner | Director | Berkeley, CA |
| Heather K Turner | Executive Officer | Berkeley, CA |
| Stig K Hansen | Director | Berkeley, CA |
| Stig K Hansen | Executive Officer | Berkeley, CA |
| Tim K Kutzky | Director | Berkeley, CA |
| Magnus K Persson | Director | San Francisco, CA |
| Stig K. Hansen | Director | San Francisco, CA |
| Stig K. Hansen | Executive Officer | San Francisco, CA |
| Dave K. Goeddel | Director | San Francisco, CA |
| Daniel A. Erlanson | Director | San Francisco, CA |
| Daniel A. Erlanson | Executive Officer | San Francisco, CA |
| Tim K. Kutzkey | Director | San Francisco, CA |
Other filings by this issuer (5)
More